In this episode, host Shikha Jain, MD, speaks with Sean Bohen, MD, about how cancer therapies are changing how oncology can be discussed, shifting from clinical to industry work and more.

•    Welcome to another exciting episode of Oncology Overdrive :58
•    About Bohen 1:04
•    The interview 1:30    
•    Tell us about your journey. How did you become an oncologist, and how did you make the transition into working in the pharmaceutical industry?  1:51
•    How did you end up at Olema Oncology after working with other pharmaceutical companies? What was your decision-making process to focus on the industry part of your career? 3:44
•    Tell us more about what Olema Oncology does and what your role is there. 6:30
•    What do you see coming down the pipeline for breast cancer research and innovation? … What do you think Olema will contribute to that space? 8:58
•    Bohen and Jain on the ways in which new treatments have resulted in shifting conversations around cancer care and patient quality of life.  12:45
•    If someone in fellowship is interested in working in industry, pharmaceuticals or scientific development, what are the most effective ways to get into this space? 18:21
•    Jain and Bohen on changing the mindset and misconceptions around moving between clinical, academic and industry work within the field and after fellowship. 20:52
•    What do you see happening in the oncology landscape twenty years from now?  25:46
•    If someone could only listen to the last two minutes of this episode, what would you want them to take away? 29:19
•    How to contact Bohen 30:54
•    Thanks for listening 31:52

Sean Bohen, MD, is the President and CEO of Olema Oncology.

We’d love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Bohen can be reached at olema.com.
 
Disclosures: Jain and Bohen report no relevant financial disclosures.